Skip to content

OSIRIS THERAPEUTICS, INC.

Delisted

CIK 1360886fmd_1HCE9BJF8MKFJ60KBVQF3Q69YJManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2009 to Dec 31, 2018, 36 periods

Latest annual · FY2018

Millions
Total revenues
143
Gross profit
105
Operating income
10
Net income
37
Free cash flow
7

Latest quarter · Q4 FY2018

Millions
Total revenues
41
Gross profit
31
Operating income
6
Net income
33
Free cash flow
(6)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2015 to FY2018
n/m
Revenue, 5 yearsFY2013 to FY2018
n/m
Net income, 5 yearsFY2013 to FY2018
n/m

OSIRIS THERAPEUTICS, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Revenue$142.8 million$118.5 million+20.5%10-K 2019-03-15 · proof
Gross profit$104.7 million$85.8 million+22%10-K 2019-03-15 · proof
Operating income$9.9 million-$2 million10-K 2019-03-15 · proof
Net income$36.9 million$8.8 million+320%10-K 2019-03-15 · proof
Cash from operating activities$7.3 million-$5.2 million10-K 2019-03-15 · proof
Free cash flow$7.1 million-$7.2 million10-K 2019-03-15 · proof
Total assets$101.5 million$78.1 million+29.9%10-K 2019-03-15 · proof
Total liabilities$23 million$36.7 million-37.4%10-K 2019-03-15 · proof
Cash and cash equivalents$16.4 million$3.1 million+431.2%10-K 2019-03-15 · proof
What was OSIRIS THERAPEUTICS, INC.'s revenue in fiscal 2018?
OSIRIS THERAPEUTICS, INC. reported revenue of $142.8 million for fiscal 2018 (the year ended Dec 31, 2018), against $118.5 million the year before (+20.5%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was OSIRIS THERAPEUTICS, INC.'s gross profit in fiscal 2018?
OSIRIS THERAPEUTICS, INC. reported gross profit of $104.7 million for fiscal 2018 (the year ended Dec 31, 2018), against $85.8 million the year before (+22%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was OSIRIS THERAPEUTICS, INC.'s operating income in fiscal 2018?
OSIRIS THERAPEUTICS, INC. reported operating income of $9.9 million for fiscal 2018 (the year ended Dec 31, 2018), against -$2 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was OSIRIS THERAPEUTICS, INC.'s net income in fiscal 2018?
OSIRIS THERAPEUTICS, INC. reported net income of $36.9 million for fiscal 2018 (the year ended Dec 31, 2018), against $8.8 million the year before (+320%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was OSIRIS THERAPEUTICS, INC.'s cash from operating activities in fiscal 2018?
OSIRIS THERAPEUTICS, INC. reported cash from operating activities of $7.3 million for fiscal 2018 (the year ended Dec 31, 2018), against -$5.2 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was OSIRIS THERAPEUTICS, INC.'s free cash flow in fiscal 2018?
OSIRIS THERAPEUTICS, INC. reported free cash flow of $7.1 million for fiscal 2018 (the year ended Dec 31, 2018), against -$7.2 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What are OSIRIS THERAPEUTICS, INC.'s total assets?
As of Dec 31, 2018, OSIRIS THERAPEUTICS, INC. reported total assets of $101.5 million, against $78.1 million a year earlier (+29.9%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What are OSIRIS THERAPEUTICS, INC.'s total liabilities?
As of Dec 31, 2018, OSIRIS THERAPEUTICS, INC. reported total liabilities of $23 million, against $36.7 million a year earlier (-37.4%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What are OSIRIS THERAPEUTICS, INC.'s cash and cash equivalents?
As of Dec 31, 2018, OSIRIS THERAPEUTICS, INC. reported cash and cash equivalents of $16.4 million, against $3.1 million a year earlier (+431.2%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1360886&period_type=annual&limit=5"

Information only, not investment advice.